Para ms informacin o contacto profesional, nuestro equipo est disponible al 809-620-8000 ext
The two pathways differ in sourcing, oversight, and cost
Clinical studies show that individuals taking Semaglutide can lose an average of 15-20% of their body weight over a year when combined with lifestyle changes
One such treatment option available at our clinic is Ozempic ( semaglutide GLP-1 ), which is typically prescribed for weight management in individuals who meet specific criteria, particularly those with obesity or overweight combined with at least one weight-related health condition
Obesity, a growing global health concern, is linked to genetic, environmental, and lifestyle factors that increase the risk of chronic diseases such as type 2 diabetes, cardiovascular disease, common cancers, and osteoarthritis, as well as significantly increasing healthcare costs during childhood and adolescence
Calcif Tissue Int 110:576591 [DOI] [PubMed] [Google Scholar] 9.Zibellini J, Seimon RV, Lee CM et al (2015) Does diet-induced weight loss lead to bone loss in overweight or obese adults